跳至主要内容
临床试验/IRCT20161022030424N11
IRCT20161022030424N11招募中3 期

Effect of a medium-chain triglyceride (MCT)-Based Ketogenic Dietary Intervention along with high-dose intravenous ascorbic acid among overweight/obese patients with triple-negative breast cancer

Tabriz University of Medical Sciences0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • 18 to 70 years old
  • Pathologically confirmed early-stage triple-negative breast cancer subtype
  • 1–3 positive axillary lymph nodes
  • Histological grades I-III
  • Unilateral cancer
  • A body mass index (BMI) of 25 kg/m2 and higher

排除标准

  • Serious cardiovascular disease
  • Cognitive impairment
  • Metabolic defects as a contraindication against ketogenic diet
  • Who are considered unsuitable for the trial by the principal investigator because of abnormal blood indices or other reasons
  • Use of systemic corticosteroids within one week of trial entry
  • Receipt of chemotherapy within two week of trial entry
  • Prior monoclonal antibody therapy within 1 month of trial entry

研究者

相似试验